Jeff Geschwind connects tumor metabolism behavior with advanced Cone Beam CT imaging to refine TACE workflows. His innovations enable selective targeting of tumor vessels, optimizing treatment response and shaping future standards in interventional liver cancer care. https://sciprofiles.com/profile/2296312?utm_source=mdpi.com&utm_medium=website&utm_campaign=avatar_name